-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse FrankfurtEURISIN US4781601046-
Johnson & JohnsonBörse Börse FrankfurtISIN US4781601046EURSymbol JNJ
-
Johnson & JohnsonBörse Börse StuttgartEURSymbol JNJ
-
Johnson & JohnsonBörse Börse MünchenEURSymbol JNJ
-
Johnson & JohnsonBörse Börse BerlinEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Xetra FrankfurtEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Gettex System der Börse MünchenEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol JNJ
-
JOHNSON & JOHNSONBörse Quotrix System der Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse DüsseldorfEURSymbol JNJ
-
JOHNSON & JOHNSONBörse Börse HamburgEURSymbol JNJ
-
USDJohnson & JohnsonBörse SGO
-
USDJohnson & JohnsonBörse BUE
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa de Comercio de Buenos Aires
-
Johnson & JohnsonBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
Johnson & JohnsonBörse SSE
-
ISIN US4781601046
Symbol JNJ
Währung
EUR
Börse
Börse Frankfurt Zeitzone: Europe/Berlin
Marktkapitalisierung
99.567.000.000
Mitarbeiter
141.700
Zahlte zuletzt am 25.05.2021 eine Dividende von 1,06 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Die Dividendenrendite
entsprach 14,66 % p. a.
beim aktuellen Kurs von 137,58 EUR +0,02%
Aktionärsstruktur der Johnson & Johnson
Portrait der Johnson & Johnson Aktie
Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.
Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor MSCI USA Quality UCITS ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Johnson & Johnson?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
2.612 News & Informationen zur Johnson & Johnson Aktie
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …
US pension fund teams up with academics to cut through ESG fog
State fund and MIT’s business school look to improve ESG data and to reflect all investors’ views
Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know
Johnson & Johnson (JNJ) closed the most recent trading day at $160.65, moving +1.75% from the previous trading session.
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
Those are some solid endorsements.
Buy Or Sell Johnson & Johnson: Keeping up with the Joneses
So if I buy Johnson & Johnson, and can live off the dividend stream, and in 30 years it is at $600/share, paying $18/share in dividends
Pfizer Leads Vaccine Stocks As The Most Trusted Name In Covid-19: IBD/TIPP
A growing number of Americans are willing to get a coronavirus vaccine, according to the latest IBD/TIPP Poll. That could help vaccine stocks.
Johnson & Johnson hat positive Nachrichten in Sachen Corona-Impfstoff
Johnson-&-Johnson-CEO kritisierte die Ausschreitungen in Washington scharf. Auch bei George Floyd meldete er sich zu Wort
Data show COVID-19 vaccine from Johnson & Johnson spurs immune response
A one-shot COVID-19 vaccine developed by Johnson & Johnson is safe and generates an immune response to block the novel coronavirus that causes the disease, according to results of an early-stage clinical trial.
Johnson & Johnson COVID-19 vaccine generates immune response in trial
Johnson & Johnson's coronavirus vaccine generated a lasting immune response to the deadly bug in an early-stage clinical trial, the pharmaceutical giant said.
J&J's COVID-19 vaccine candidate shows it generates antibodies in early-stage trial
Shares of Johnson & Johnson undefined gained 1.7% in premarket trading on Thursday, the day after a study published in the New England Journal of Medicine…
Johnson & Johnson: Zulassung von Corona-Impfstoff im ersten Quartal?
Es wird große Hoffnung in den Impfstoff gesetzt: Im Gegensatz zu den anderen ist bei ihm nur eine einzige Impfdosis nötig.
Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated
(RTTNews) – Johnson & Johnson announced that its Covid-19 vaccine candidate, JNJ-78436735, being developed by its unit Janssen Pharmaceutical Comp…
Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated
Johnson & Johnson announced that its Covid-19 vaccine candidate, JNJ-78436735, being developed by its unit Janssen Pharmaceutical Companies and currently undergoing in a Phase 3 trial, has been found to be safe and well tolerated.
5 Stocks To Watch For January 14, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Delta Air Lines, Inc. (NYSE: DAL) to report a quarterly loss at $2.50 per …
Covid-19 vaccine doses secured for Africa
The African Vaccine Acquisition Task Team (AVATT) has confirmed the acquisition of provisional 270 million vaccine doses for African countries, with at least 50…
Johnson & Johnson's one shot Covid vaccine grants lasting response in trial
Read more about Johnson & Johnson's one shot Covid vaccine grants lasting response in trial on Business Standard. More than 90% of participants made immune proteins, called neutralizing antibodies, within 29 days after receiving the shot, according to the report
Johnson & Johnson vaccine on track for March rollout
The pharmaceutical company said it is hoping to deliver 1 billion injections of its one-dose vaccine by the end of this year.
Venture Capital Access Online
Johnson & Johnson : Favorable Data Published About Johnson & Johnson Covid-19 Vaccine, CNBC Says
–The New England Journal of Medicine published favorable clinical trial data about Johnson & Johnson's potential Covid-19 vaccine, including data about safety and immune response, CNBC… | January 13, 2021
The Dow Slipped 8 Points, but Big Tech Stocks Powered Higher
Apple, Amazon, Netflix, and Microsoft stock ended with material gains, as value stocks reeled. Johnson & Johnson slipped on a report it was seeing delays in…
J&J COVID-19 vaccine could be available in Europe in April – source
Johnson & Johnson could deliver the first doses of its COVID-19 vaccine to Europe in April, an EU official told Reuters on Wednesday after a top lawmaker said the U.S. healthcare company was…
Johnson & Johnson vaccine results to arrive, supply lags – NYT (Updated) (NYSE:JNJ)
NIO : Thinking about trading options or stock in Nio, Ford Motor, Johnson & Johnson, Moderna, or General Motors?
NEW YORK, Jan. 13, 2021 /PRNewswire/ –?InvestorsObserver issues critical PriceWatch Alerts for NIO, F, JNJ, MRNA, and GM.
… | January 13, 2021
Stocks mixed as House readies Trump impeachment vote
Investors treaded lightly as the House of Representatives was set to begin impeachment proceedings against President Trump.
J&J likely to apply for EU approval for vaccine in February: Lawmaker
Read more about J&J likely to apply for EU approval for COVID vaccine in February – lawmaker on Business Standard. BRUSSELS (Reuters) – U.S. firm Johnson & Johnson is likely to apply for EU approval for its COVID-19 vaccine candidate in February, a top lawmaker said on Wednesday.
Corona-Impfpass: Mit Impfung & EU-weitem Zertifikat reisen können
Beim Corona-Impfpass unterstützt EVP-Fraktionschef Manfred Weber den Vorschlag Griechenlands. EU-Bewohner sollen nach Corona-Impfungen bald frei reisen können.
3 Dividend Aristocrats to Buy Right Now
These stocks are as solid as they come.
Johnson & Johnson vaccine production is behind schedule: report
Federal officials have been told that Johnson & Johnson's undefined vaccine production has fallen as much as two months behind the original production…
J&J Opposes Former Talc Supplier’s Bankruptcy Plan to Resolve Cancer Claims
Imerys SA is pressing ahead in an effort to get out from under lawsuits over its U.S. mining operation, Imerys Talc America, over the protests of Johnson & Johnson.
Operation Warp Speed chief resigns at Biden team's request, will stay through transition, sources say
The scientific leader of the U.S. vaccine effort will stay in the role for 30 days, but won't be chief adviser as of Jan. 20, sources say.
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
Johnson & Johnson (JNJ) closed at $158.13 in the latest trading session, marking a -0.78% move from the prior day.
Vaccine Rollout, Herd Immunity to End Pandemic
COVID will create a US$ 39bn vaccine and treatment market and usher in immunity by 2023, writes Morningstar's Karen Andersen.
Equities Beat A Gentle Retreat
Market Overview Analysis by MarketPulse (Jeffrey Halley) covering: XAU/USD, Pfizer Inc, Johnson & Johnson, US Dollar Index Futures. Read MarketPulse (Jeffrey Halley)'s latest article on Investing.com
Johnson & Johnson (JNJ) Stock Moves -0.42%: What You Should Know
In the latest trading session, Johnson & Johnson (JNJ) closed at $159.37, marking a -0.42% move from the previous day.
3 Dividend Stocks to Supplement Your Social Security
When it comes to dividend payers, cash is king.
2.000 Euro auf der hohen Kante? Hier sind 3 Top-Aktien für 2021
Diese unaufhaltsamen Aktien drucken förmlich Geld.
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Jan. 7) …
Aspen set to benefit from SA’s vaccine rollout if J&J gets green light
South Africa’s Aspen Pharmacare has agreed to manufacture doses of the J&J vaccine in the country if it’s given the green light.
Sound Income ETFs Bring Active Approach to Creating Retirement Income
Sound Income Strategies, a Florida-based registered investment advisory firm, is making its income-generating strategies more accessible to a broader group of investors.
Sound Income ETFs Bring Active Approach to Retirement Income
Sound Income Strategies is making its income-generating strategies more accessible to a broader group of investors.